BRIEF-Genmab achieves $30 mln milestone in deal with Janssen
May 30, 2016 at 11:00 AM EDT
* Says milestone triggered by first commercial sale of Darzalex in Europe Source text for Eikon: Further company coverage: (Copenhagen newsroom)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.